Skip to main content

Table 8 In-vitro cytotoxicity of synthesized compounds against Breast cancer cell line (MCF-7) [51]

From: Therapeutic potential of oxadiazole or furadiazole containing compounds

Compound

% Viability

6.25 μg/ml

12.5 μg/ml

25 μg/ml

50 μg/ml

100 μg/ml

11a

38.04

37.15

39.68

35.11

40.31

11b

38.26

42.70

37.90

38.84

43.24

11c

44.35

41.6

41.81

39.64

37.24

11d

42.70

39.46

40.48

37.61

37.37

11e

30.60

32.20

34.48

33.86

37.54

11f

32.57

33.09

30.88

30.75

24.87

11 g

34.39

33.58

28.80

32.40

30.96

11 h

32.03

35.40

31.25

33.69

34.45

  1. Control % viability = 100